
Shafiqul Haq
Examiner (ID: 6032, Phone: (571)272-6103 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1641, 1678, 1677 |
| Total Applications | 1426 |
| Issued Applications | 808 |
| Pending Applications | 172 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19651251
[patent_doc_number] => 12173019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Protein proximity assay in formalin fixed paffafin embedded tissue using caged haptens
[patent_app_type] => utility
[patent_app_number] => 17/345072
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 34
[patent_no_of_words] => 20094
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345072 | Protein proximity assay in formalin fixed paffafin embedded tissue using caged haptens | Jun 10, 2021 | Issued |
Array
(
[id] => 18486171
[patent_doc_number] => 20230213513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Neutrophil Progenitors and Related Methods and Uses
[patent_app_type] => utility
[patent_app_number] => 18/000559
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000559
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000559 | Neutrophil Progenitors and Related Methods and Uses | Jun 10, 2021 | Pending |
Array
(
[id] => 19355115
[patent_doc_number] => 12055550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Charged mass labeling system
[patent_app_type] => utility
[patent_app_number] => 17/342804
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 17952
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342804 | Charged mass labeling system | Jun 8, 2021 | Issued |
Array
(
[id] => 19442389
[patent_doc_number] => 12092644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Kits comprising aldehydes to reduce artifacts in analyzing glycans released from glycoproteins or glycopeptides
[patent_app_type] => utility
[patent_app_number] => 17/319868
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7785
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319868 | Kits comprising aldehydes to reduce artifacts in analyzing glycans released from glycoproteins or glycopeptides | May 12, 2021 | Issued |
Array
(
[id] => 19537733
[patent_doc_number] => 12130284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Colors for chromogenic IHC and ISH staining with multi-dye quinone methide and tyramide conjugates
[patent_app_type] => utility
[patent_app_number] => 17/318541
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 23125
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318541
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318541 | Colors for chromogenic IHC and ISH staining with multi-dye quinone methide and tyramide conjugates | May 11, 2021 | Issued |
Array
(
[id] => 19263736
[patent_doc_number] => 20240207433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/998559
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998559 | DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF | May 9, 2021 | Pending |
Array
(
[id] => 17068605
[patent_doc_number] => 20210270820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => NANODIAMOND PARTICLES AND RELATED DEVICES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/316665
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316665
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316665 | NANODIAMOND PARTICLES AND RELATED DEVICES AND METHODS | May 9, 2021 | Pending |
Array
(
[id] => 18658998
[patent_doc_number] => 20230304998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => CELLULAR MATERIAL DETECTION PROBES
[patent_app_type] => utility
[patent_app_number] => 17/923262
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923262 | CELLULAR MATERIAL DETECTION PROBES | May 6, 2021 | Pending |
Array
(
[id] => 20130206
[patent_doc_number] => 12372513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Use of eomesodermin to determine risk of allograft rejection
[patent_app_type] => utility
[patent_app_number] => 17/245716
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 23
[patent_no_of_words] => 5238
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245716 | Use of eomesodermin to determine risk of allograft rejection | Apr 29, 2021 | Issued |
Array
(
[id] => 19978169
[patent_doc_number] => 12345641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Fluorescence quenching immunoassay
[patent_app_type] => utility
[patent_app_number] => 17/232647
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 70
[patent_no_of_words] => 36539
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232647 | Fluorescence quenching immunoassay | Apr 15, 2021 | Issued |
Array
(
[id] => 18552332
[patent_doc_number] => 20230250341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => SOLUBILIZING AGENT AND SOLUBILIZING SOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/996470
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996470 | SOLUBILIZING AGENT AND SOLUBILIZING SOLUTION | Apr 12, 2021 | Pending |
Array
(
[id] => 16993252
[patent_doc_number] => 20210231672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => PROTEIN INTERACTOR DETECTION SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/227055
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227055 | PROTEIN INTERACTOR DETECTION SYSTEMS | Apr 8, 2021 | Abandoned |
Array
(
[id] => 18421601
[patent_doc_number] => 20230176065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => METHOD OF DETECTING AN ANALYTE
[patent_app_type] => utility
[patent_app_number] => 17/916289
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916289 | METHOD OF DETECTING AN ANALYTE | Mar 30, 2021 | Pending |
Array
(
[id] => 19360894
[patent_doc_number] => 20240262928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Composition and Method
[patent_app_type] => utility
[patent_app_number] => 17/907471
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907471
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907471 | Composition and Method | Mar 25, 2021 | Pending |
Array
(
[id] => 19579868
[patent_doc_number] => 12145964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Thiophosphorodichloridate reagents for chemoselective histidine bioconjugation
[patent_app_type] => utility
[patent_app_number] => 17/207609
[patent_app_country] => US
[patent_app_date] => 2021-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 16
[patent_no_of_words] => 7517
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207609 | Thiophosphorodichloridate reagents for chemoselective histidine bioconjugation | Mar 19, 2021 | Issued |
Array
(
[id] => 17113214
[patent_doc_number] => 20210293811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => TARGET INTERFERENCE MITIGATION IN ANTI-DRUG ANTIBODY ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/203566
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203566 | TARGET INTERFERENCE MITIGATION IN ANTI-DRUG ANTIBODY ASSAY | Mar 15, 2021 | Pending |
Array
(
[id] => 18307812
[patent_doc_number] => 20230111712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => STABLE REACTIVE COMPOSITIONS FOR BIOCONJUGATION, PROBES, AND PROTEIN LABELING
[patent_app_type] => utility
[patent_app_number] => 17/905787
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905787 | STABLE REACTIVE COMPOSITIONS FOR BIOCONJUGATION, PROBES, AND PROTEIN LABELING | Mar 14, 2021 | Pending |
Array
(
[id] => 17098146
[patent_doc_number] => 20210285937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => MULTIPLEXED COLOCALIZATION-BY-LINKAGE ASSAYS FOR THE DETECTION AND ANALYSIS OF ANALYTES
[patent_app_type] => utility
[patent_app_number] => 17/200680
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200680 | MULTIPLEXED COLOCALIZATION-BY-LINKAGE ASSAYS FOR THE DETECTION AND ANALYSIS OF ANALYTES | Mar 11, 2021 | Pending |
Array
(
[id] => 18725881
[patent_doc_number] => 20230340114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/905943
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905943
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905943 | NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS | Mar 11, 2021 | Pending |
Array
(
[id] => 16933757
[patent_doc_number] => 20210199646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => SAMPLE DEPLETION AND ENRICHMENT TO IMPROVE THE QUALITY OF DIAGNOSTIC TEST RESULTS
[patent_app_type] => utility
[patent_app_number] => 17/199228
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199228 | SAMPLE DEPLETION AND ENRICHMENT TO IMPROVE THE QUALITY OF DIAGNOSTIC TEST RESULTS | Mar 10, 2021 | Pending |